Surprising lack of association between stress and migraine revealed
Surprising it might sound, but a new study has found lack of association between stress and migraine.
The research by the University of Calgary and...
Oramed provides doses to patients across multiple sites
Oramed Pharmaceuticals Inc has announced that randomization of patients in its first Phase 3 study of its oral insulin capsule ORMD-0801 for the treatment...
Is immediate immunity against COVID-19 possible? Grifols starts clinical trial of new treatment
Grifols has announced it will begin a clinical trial in Spain to evaluate the safety and efficacy of a new COVID-19 immunity drug based...
Soterix announces expanded clinical trials for Alzheimer’s disease
Soterix Medical Inc has announced expanded clinical trials of its proprietary neuromodulation technologies for Alzheimer's disease and Mild Cognitive Impairment.
The company is a leaing...
Covid-19 investigational therapeutics to be analysed in big clinical trials
Covid-19 investigational therapeutics are to be evaluated in large clinical trials. Two controlled, randomized Phase 3 clinical trials have started evaluating investigational monoclonal antibodies...
NIH starts study of Covid infection and multisystem inflammatory syndrome
NIH has started an observational study has launched to evaluate the short- and long-term health outcomes of SARS-CoV-2 infection in children
This includes multisystem inflammatory...
Codagenix, Serum Institute of India start first-in-human trial of Covid-19 vaccine
Codagenix, Inc., and the Serum Institute of India Pvt. Ltd. (SIIPL) have announced that a Phase 1 clinical trial of COVI-VAC received regulatory approval...
Lilly’s tirzepatide brings down body weight in people with type 2 diabetes
Lilly's Tirzepatide led to superior A1C and body weight reductions from baseline in adults with type 2 diabetes.
This was achieved after 40 weeks of...
Covid immunity lasts for many months, says study of healthcare workers
In a relief to healthcare workers who put their lives under risk while treating those with Covid-19, new findings from a study of thousands...
FDA gives nod to Saxenda for adoloscents’ obesity treatment
Novo Nordisk has said that the United States Food and Drug Administration (FDA) approved an updated label for Saxenda (liraglutide) injection 3 mg for...
